Delivery Order SPE2DB22D1106-SPE2DB25FFFQ3
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,397.27 on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.66 to AmerisourceBergen Drug Corp for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The award was made on May 16, 2025, with an ultimate completion date of May 19, 2025, utilizing firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $7,966.52 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price contract, with an ultimate completion date of July 24, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's existing pharmaceutical supply vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $14,858.01 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 21, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $165,523.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. The contract, which was not set-aside and competitively awarded, is scheduled for completion by September 5, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $237,587.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Menveo 1 vial (meningococcal conjugate vaccine) with completion targeted for August 27, 2025. This non-set-aside award, issued on August 26, 2025, represents a single delivery order fulfillment from AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $61,593 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, was competitively awarded without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill the delivery order from its corporate office location. This contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine product with a ceiling value of $3,659.10. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The order is scheduled...
- The Defense Logistics Agency awarded a delivery order valued at $10,245.48 to AmerisourceBergen Drug Corp for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a non-competitive, direct award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is the contractor's corporate office...
- The Defense Logistics Agency awarded a $2,195.49 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The order is scheduled for completion by June 2, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFFQ3Delivery Order
The Defense Logistics Agency awarded a $43,115.10 delivery order to AmerisourceBergen Drug Corp for MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine product. This firm fixed price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive, non-set-aside award executed through AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is listed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls under AmerisourceBergen's substantial $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (vehicle SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare systems. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a broad range of medical products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This particular vaccine procurement supports the military's immunization requirements and reflects the company's role as a key provider of specialized medical commodities across multiple therapeutic domains for defense health operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.1k | 8/27/25 |